Advertisement

Is Genes in the Mouse

  • N. A. Mitchison

Abstract

Progress in understanding suppressor T cells since the last International Congress can be summarised in the following terms. The phenomenon of suppression of this type has not been seriously challenged, and instances of suppression continue to accrue. Some are in areas of clinical relevance, such as organ transplantation (Gassel 1987). Others are in branches of immunology opened up by molecular genetics such as the new array of mycobacterial antigens (Ivanyi 1989). There have also been setbacks. For instance one of the best pointers to suppression has been dominant inheritance of unresponsiveness. MHC-controlled dominant unresponsiveness to a particular antigen never provided more than a clue that suppression might be operating, but nevertheless it served as a source of encouragement. Now it has become clear that a second major cause of such unresponsiveness operates through deletion of large segments of the T-cell-repertoire by negative selection in the thymus (McDuffie 1988). MHC molecules are powerful inducers of tolerance, and as such can delete the T-cell response not only to themselves but also to other antigens. This discovery significantly weakens the value of dominant unresponsiveness as a clue for suppression. Another setback has been in the area of suppressor epitopes.

Keywords

Suppressor Cell Mycobacterial Antigen Lepromatous Leprosy Veto Cell Processing Epitope 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alexander DR, Cantrell DA (1989) Immunol Today 10:200–205PubMedCrossRefGoogle Scholar
  2. Baxevanis CN, Nagy ZA, Klein J (1981) Proc Natl Acad Sci USA 78:3809–3813PubMedCentralPubMedCrossRefGoogle Scholar
  3. Batchelor JR, Lombardi G, Lechler RI (1989) Immunol Today 10:37–40PubMedCrossRefGoogle Scholar
  4. Damle NK, Mohagheghpour N, Engle.man EG (1984a) J Immunol 133:1235–1240PubMedGoogle Scholar
  5. Fisher AG, Goff LK, Lightstone E, Marvel J, Mitchison NA, Poirier Stauss H, Zamoyska (1989) Problems in the physiology of class I and class II MHC molecules, and of CD45. Cold Spring Harbor Symp Quant Biol 54Google Scholar
  6. Gassel HJ, Hutchinson IV, Engemann R, Morris P (1987) Transplant Proc 19:4207–4209PubMedGoogle Scholar
  7. Germain RN and Benacerraf B (1981) Scand J Immunol 13:1–10PubMedCrossRefGoogle Scholar
  8. Groux H, Huet S, Valentin H, Pham D, Bernard A (1989) Nature 339: 152–154PubMedCrossRefGoogle Scholar
  9. Ishizaka K (1988) Ann Rev Immunol 6:513–534CrossRefGoogle Scholar
  10. Ivanyi J, Sharpe K (1986) Immunology 59:329–332PubMedCentralPubMedGoogle Scholar
  11. Jenkins MK, Ashwell JD, Schwartz RH (1988) J Immunol 140:3324–3330PubMedGoogle Scholar
  12. Kuchroo VK, Steele JK, Billing PR, Selvaraj P, Dorf ME (1988) Proc Natl Acad Sci USA 85:9209–9213PubMedCentralPubMedCrossRefGoogle Scholar
  13. Marvel J, Mayer A (1988) Eur J Immunol 18:825–828PubMedCrossRefGoogle Scholar
  14. McDuffie M, Roehn N, Kappler JW, Marrack P (1988) J Immunol 141: 1840–1847PubMedGoogle Scholar
  15. Merkenschlager M, Terry L, Edwards R, Beverley PCL (1988) Eur J Immunol 18:1653–1661PubMedCrossRefGoogle Scholar
  16. Mitchison NA (1989) Chemical Immunology 46:157–166PubMedCrossRefGoogle Scholar
  17. Mitchison NA (1988) Scand J Immunol 28:271–276PubMedCrossRefGoogle Scholar
  18. Mitchison NA, Oliveira DBG (1986) Epirestriction and a specialised subset of T helper cells are key factors in the regulation of T suppressor cells. In: Cinader B, Miller RG (eds) Progress in Immunology VI. Sixth International Congress of Immunology, Academic Press, London, p326Google Scholar
  19. Mitchison NA, Oliveira DBG (1986) Parasitol Today 2:312–313PubMedCrossRefGoogle Scholar
  20. Mitchison NA, 0’Malley C (1987) Eur J Immunol 17: 579–583CrossRefGoogle Scholar
  21. Nakayama T, Kubo RT, Kishimoto H, Asano Y, Tada T (1989) 1:50–58Google Scholar
  22. O’Hara RM, Sherr DH, Dorf ME (1988) J Immunol 141:2935–2942PubMedGoogle Scholar
  23. Oliveira DBG, Mitchison NA (1989) Clin Exp Immunol 75:167–177PubMedCentralPubMedGoogle Scholar
  24. Pene J, Rousset F, Briere F, Chretien I, Bonnejoy-JY, Spits H, Yokata T, Arai K, Banchereau J (1988) Proc Natl Acad Sci USA 85: 6880–6884PubMedCentralPubMedCrossRefGoogle Scholar
  25. Powrie F, Mason D (1989) J Exp Med 169:653–662PubMedCrossRefGoogle Scholar
  26. Ranges GE, Figari IS, Espevik T, Palladino MA (1987) J Exp Med 166 991–998PubMedCrossRefGoogle Scholar
  27. Sercarz EE (1986) Concepts Immunopathol 3:61–73PubMedGoogle Scholar
  28. Shinohara N, Watanabe M, Sachs DH, Hozumi N (1988) Nature 336:481–484PubMedCrossRefGoogle Scholar
  29. Unkeless JC, Scigliano E, Freedman VH (1988) Ann Rev Immunol 6:251 281Google Scholar
  30. Weaver D, Reis MH, Albanese C, Constantini F, Baltimore D, Imanishi-Kari T (1986) Cell 45:247–259PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • N. A. Mitchison

There are no affiliations available

Personalised recommendations